• Tubastatin A: Precision HDAC6 Inhibition for Cardiac and Neu

  2026-07-21

  Explore the multifaceted research applications of Tubastatin A, a potent HDAC6 inhibitor, in cardiac and neurological protection. This article unveils mechanistic insights and practical guidance for assay design, setting it apart from existing content.

• Hexamethonium Bromide: Expanding the Frontiers of Autonomic

  2026-07-21

  Explore how Hexamethonium Bromide, a selective antagonist of neuronal-type nicotinic AChR, enables advanced research into sex-specific autonomic regulation. This article uniquely synthesizes mechanistic insights and assay design strategies for translational neuroscience.

• AZD1480: JAK2 Inhibitor Workflows for Tumor STAT3 Pathway An

  2026-07-20

  AZD1480 from APExBIO delivers precision for dissecting JAK2/STAT3 signaling in cancer models, enabling both standalone and combination strategies. This guide translates emerging evidence into actionable protocols, troubleshooting, and novel application insights for tumor biology research.

• Angiotensin 1/2 (2-7) Peptide: Bridging Cardiovascular and V

  2026-07-20

  Explore the unique dual role of the Angiotensin 1/2 (2-7) peptide in blood pressure regulation and SARS-CoV-2 spike protein binding. This article provides advanced insight into its molecular mechanisms and translational research value.

• TBST’s Translational Power: Precision Blocking in uPAR–uPA S

  2026-07-19

  Explore how TBST (Tris-Buffered Saline and Tween 20) transforms immunoassay workflows for translational cancer research, with mechanistic insights from uPAR–uPA interaction studies and actionable guidance to optimize assay reproducibility and clinical relevance.

• Verapamil ((±)-Verapamil): Applied Protocols in Hypoxia Rese

  2026-07-18

  Verapamil ((±)-Verapamil) extends well beyond cardiovascular models, uniquely enabling dissection of ROS/TXNIP/NLRP3-driven inflammation in hypoxia-exposed cells. From optimizing protocols to troubleshooting P-glycoprotein interactions, this article delivers actionable insights for modern research teams.

• Sitagliptin Phosphate Monohydrate: DPP-4 Inhibitor Mechanism

  2026-07-17

  Sitagliptin phosphate monohydrate is a potent, selective DPP-4 inhibitor central to type II diabetes treatment research. It increases levels of incretin hormones by blocking DPP-4 and has demonstrated efficacy in metabolic and vascular models. APExBIO supplies validated, high-purity Sitagliptin phosphate monohydrate for research applications.

• Pathogen-Driven Identification of Macrophage Bacterial Killi

  2026-07-17

  Russell et al. introduce a pathogen-centric approach to discover host factors vital for macrophage-mediated killing of gram-positive bacteria. By leveraging adaptive variation in hypervirulent Streptococcus pneumoniae, the study reveals NAMPT, ACOD1/itaconate, and P2RX7 as actionable targets for host-directed therapies.

• Nav1.5 Ser571 Phosphorylation Drives Age-Related Cardiac Dys

  2026-07-16

  This study reveals that phosphorylation of the cardiac sodium channel Nav1.5 at Ser571 increases the late sodium current, leading to delayed ventricular repolarization and diastolic dysfunction in aging hearts. These mechanistic insights clarify the molecular basis behind age-associated cardiac electrical and mechanical deficits and highlight new directions for arrhythmia prevention research.

• Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe): Experiment

  2026-07-16

  Angiotensin II (SKU A1042) enables reproducible modeling of hypertension mechanisms, vascular smooth muscle cell hypertrophy, and cardiovascular remodeling in cell and animal systems. This guide clarifies recommended preparation, administration, and troubleshooting for research-only contexts. Use is not advised outside of mechanistic or preclinical studies due to its restriction to non-clinical applications.

• Bradykinin (BA5201): Technical Guidance for Vascular Researc

  2026-07-15

  Bradykinin (SKU BA5201) addresses the need for a reliable endothelium-dependent vasodilator peptide in research focused on blood pressure regulation, vascular permeability, and inflammation signaling. This product is best used in controlled laboratory settings for cardiovascular and inflammation research and is not appropriate for diagnostic or medical applications.

• Amitriptyline HCl: Optimizing Neurotransmitter Modulation Wo

  2026-07-15

  Amitriptyline HCl delivers robust, reproducible multi-receptor inhibition for advanced neuropharmacology and mood disorder research. This article unpacks experimental workflows, troubleshooting strategies, and translational insights, leveraging APExBIO’s high-purity formulation to maximize impact in both established and emerging assay models.

• Bsa I (RNase-free): Technical Guidance for DNA Cleavage

  2026-07-14

  Bsa I (RNase-free) enables precise DNA cleavage in research applications demanding strict RNA preservation, such as gene cloning and DNA recombinant technology. It is not suitable for diagnostic, clinical, or medical use, and should be implemented strictly within molecular biology research workflows requiring RNase-free conditions.

• CDK9 Inhibitor (A3294): Technical Use and Workflow Guidance

  2026-07-14

  CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor designed for research requiring targeted modulation of CDK9 activity, especially in transcription elongation and HIV-1 propagation studies. It is not suitable for protocols demanding broad-spectrum CDK inhibition or long-term storage of working solutions.

• Masitinib (AB1010): Technical Guidance for KIT/PDGFR Assays

  2026-07-13

  Masitinib (AB1010) offers a selective approach for researchers investigating KIT and PDGFR tyrosine kinase pathways, particularly in cancer, mastocytosis, and inflammatory disease models. It is best used in DMSO-based assays requiring high kinase selectivity and is not suitable for protocols needing aqueous or ethanol solubility or broad-spectrum kinase inhibition.

16291 records 1/1087 page Next 12345 下5页 Last page